VEGF/VEGFR inhibitors

Cyramza 500 mg/50 mL (10 mg/mL) injection Images

Generic Name: ramucirumab

This medication has been identified as Cyramza 500 mg/50 mL (10 mg/mL) injection. It is supplied by Eli Lilly and Company.

Cyramza is used in the treatment of Hepatocellular Carcinoma; Gastric Cancer; Non-Small Cell Lung Cancer; Colorectal Cancer; Stomach Cancer and belongs to the drug class VEGF/VEGFR inhibitors. Risk cannot be ruled out during pregnancy. Cyramza 500 mg/50 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images

Cyramza (Ramucirumab [ ra-mue-sir-ue-mab ])-medicine-500 mg/50 mL (10 mg/mL) injection

Cyramza
Generic Name: ramucirumab [ ra-mue-sir-ue-mab ]
Imprint: medicine
Strength: 500 mg/50 mL (10 mg/mL) injection
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: VEGF/VEGFR inhibitors
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00002-7678
Inactive Ingredients:
Latest News
Related Drugs